Acorda Therapeutics ACOR

Quarterly report 2024-Q1
added 05-14-2024

Acorda Therapeutics DIO Ratio 2011-2026 | ACOR

Annual DIO Ratio Acorda Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
345	188	211	312	264	107	101	146	143	122	143	133	156

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
345	101	182

Quarterly DIO Ratio Acorda Therapeutics

2024-Q1	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
340	370	-	127	156	255	-	158	213	214	-	215	393	640	-	288	245	281	-	105	87.2	147	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
640	87.2	249

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Grifols, S.A. GRFS	0.000171	$ 7.71	1.65 %	$ 6.83 B	Spain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Heron Therapeutics HRTX	644	$ 0.8	2.5 %	$ 133 M	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Incyte Corporation INCY	78.4	$ 90.82	0.04 %	$ 17.7 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	InMed Pharmaceuticals INM	309	$ 0.79	-3.52 %	$ 1.93 M	Canada
	Clovis Oncology CLVS	271	-	-7.23 %	$ 13 M	USA
	CorMedix CRMD	308	$ 6.35	1.6 %	$ 457 K	USA
	Kamada Ltd. KMDA	166	$ 8.33	0.97 %	$ 260 M	Israel